Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

SRx Health Solutions (SRXH) Non Operating Investment Income (2017 - 2020)

SRx Health Solutions' Non Operating Investment Income history spans 4 years, with the latest figure at $102000.0 for Q4 2020.

  • For Q4 2020, Non Operating Investment Income rose 213.33% year-over-year to $102000.0; the TTM value through Dec 2020 reached -$538000.0, down 167.59%, while the annual FY2020 figure was $2.2 million, 2566.67% up from the prior year.
  • Non Operating Investment Income reached $102000.0 in Q4 2020 per SRXH's latest filing, down from $4.2 million in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of $4.2 million in Q3 2020 to a low of -$3.5 million in Q2 2020.
  • Average Non Operating Investment Income over 4 years is -$49491.4, with a median of -$75998.0 recorded in 2017.
  • The largest YoY upside for Non Operating Investment Income was 290.45% in 2020 against a maximum downside of 1700.0% in 2020.
  • A 4-year view of Non Operating Investment Income shows it stood at $111281.0 in 2017, then soared by 182.19% to $314021.0 in 2018, then tumbled by 128.66% to -$90000.0 in 2019, then soared by 213.33% to $102000.0 in 2020.
  • Per Business Quant, the three most recent readings for SRXH's Non Operating Investment Income are $102000.0 (Q4 2020), $4.2 million (Q3 2020), and -$3.5 million (Q2 2020).